Multi-Omics Integration for Advancing Glioma Precision Medicine

Area of Science:

• Neuro-oncology
• Computational Biology
• Genomics

Background:

• Gliomas are aggressive central nervous system tumors with poor prognosis and limited effective treatments.
• Current diagnosis and management, often based on single genetic markers, struggle to capture tumor complexity.
• High-throughput technologies have enabled molecular classification but challenges remain in clinical application.

Purpose of the Study:

• To provide an overview of multi-omics strategies for adult-type diffuse glioma molecular taxonomy.
• To highlight the potential of integrating diverse omics data for improved glioma understanding.
• To explore how computational methods enhance diagnostic precision, prognostic accuracy, and therapeutic development.

Main Methods:

• Comprehensive review of multi-omics data integration strategies (genomics, transcriptomics, epigenomics, proteomics, metabolomics, radiomics, single-cell, spatial omics).
• Focus on computational methodologies and artificial intelligence (machine learning algorithms).
• Analysis of sex-dependent differential gene expression patterns.

Main Results:

• Multi-omics integration offers a deeper understanding of glioma biology.
• Combined data and machine learning improve diagnostic precision and prognostic accuracy.
• This integrated approach facilitates personalized and targeted therapeutic interventions.

Conclusions:

• Multi-omics data integration is crucial for deciphering glioma molecular taxonomy.
• Machine learning-based analysis of multilayer data advances glioma patient prognosis.
• The future of glioma treatment lies in personalized, targeted therapies informed by comprehensive molecular insights.